The role of organoids in cancer research.

Publication Year: 2023

DOI:
10.1186/s40164-023-00433-y

PMCID:
PMC10401879

PMID:
37537666

Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare no competing interests. AbbreviationsThree-dimensional (3D); Patient-derived tumor organoids (PDTOs); Extracellular Matrix (ECM); Engelbreth-Holm-Swarm (EHS); Mesenchymal stem cells (MSC); Induced Pluripotent Stem Cells (iPSCs); EGF, Noggin, R-spondin (ENR); Colorectal cancer (CRC); Embryonic stem cells (ESCs); Adult stem cells (ASCs); Human pluripotent stem cell (hPSC); Circulating tumor cells (CTCs); Patient Derived Organoid (PDO); Rhabdomyosarcomas (RMS); Tumor-infiltrating lymphocytes (TILs); Food and Drug Administration (FDA); β-hydroxybutyrate (BHB); Cancer-associated fibroblasts (CAFs). Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This paper was supported by the National Natural Science Foundation of China (82203854); Key Research and Development Program of Shandong Province (No.2019JZZY010104; 2021CXGC011104); Special Foundation for Taishan Scholars Program of Shandong Province (No.ts20190978); Academic promotion programme of Shandong First Medical University (No. 2019QL021)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025